Browse > Article

Comparison of the Therapeutic Efficacy of Rhizoma Alismatis, Fructus Crataegi, Fructus Lycii, Radix Curcumae, Radix Salviae Miltiorrhizae, Herba Artemisiae Scopariae on the Experimental Cellular Model of Nonalcoholic Fatty Liver Disease  

Han, Chang-Woo (Dept. of Internal Medicine, School of Korean Medicine, Pu-San National University)
Joo, Myung-Soo (Division of Applied Medicine, School of Korean Medicine, Pu-San National University)
Lee, Jang-Hoon (Dept. of Internal Medicine, College of Korean Medicine, Kyung-Hee University)
Publication Information
The Journal of Internal Korean Medicine / v.33, no.4, 2012 , pp. 533-542 More about this Journal
Abstract
Objectives : We try to compared the efficacy of six herbal medicines, Rhizoma Alismatis (RA), Fructus Crataegi (FC), Fructus Lycii (FL), Radix Curcumae (RC), Radix Salviae Miltiorrhizae (RSM), and Herba Artemisiae Scopariae (HAS), constituting KHchunggan-tang which was previously proven to be hepatoprotective on non-alcoholic fatty liver disease with combined properties of cellular steatosis, ROS production, and cytoprotection. Methods : HepG2 cells were pretreated with aqueous extracts of the six herb medicines at concentrations of 1, 10, 50 and 100 ${\mu}g/ml$ each, and treated with 0.5 mM palmitate consecutively. After 21 hrs, cell viability was assessed using MTT assay, and the percentage of cells with sub-G1 DNA content was measured using fluorescence-activated cell sorting after propidium iodide staining. Results : The first three extracts, RA, FC, and FL restored cell viability reduced by palmitate in MTT assay, and RA, FC, FL and RC inhibited palmitate-induced apoptosis in sub-G1 analysis. FL showed relatively weak potential only at tested maximal dose, and RA showed the greatest higher efficacy on this experimental cellular model of nonalcoholic fatty liver disease. Conclusions : According to this comparative experiment, Rhizoma Alismatis seems to have the most powerful potential among the six herbs constituting KHchunggan-tang, and consecutive further study seems to be required for more standardized and effective clinical application of KHchunggan-tang for treatment of non-alcoholic fatty liver disease.
Keywords
nonalcoholic fatty liver disease; KHchunggan-tang; Rhizoma Alismatis;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Ji W, Gong BQ. Hypolipidemic activity and mechanism of purified herbal extract of Salvia miltiorrhiza in hyperlipidemic rats. J Ethnopharmacol 2008;119(2):291-8.   DOI   ScienceOn
2 Kang DG, Yun YG, Ryoo JH, Lee HS. Anti-hypertensive effect of water extract of danshen on renovascular hypertension through inhibition of the renin angiotensin system. Am J Chin Med 2002;30(1):87-93.   DOI   ScienceOn
3 Liu G, Guan GJ, Qi TG, Fu YQ, Li XG, Sun Y, et al. [Protective effects of Salvia miltiorrhiza on rats with streptozotocin diabetes and its mechanism]. Zhong Xi Yi Jie He Xue Bao 2005;3(6):459-62.   DOI   ScienceOn
4 Kim SK, Jung KH, Lee BC. Protective effect of Tanshinone IIA on the early stage of experimental diabetic nephropathy. Biol Pharm Bull 2009;32(2):220-4.   DOI   ScienceOn
5 Okuno I, Uchida K, Kadowaki M, Akahori A. Choleretic effect of Artemisia capillaris extract in rats. Jpn J Pharmacol 1981;31(5):835-8.   DOI
6 Hong JH, Hwang EY, Kim HJ, Jeong YJ, Lee IS. Artemisia capillaris inhibits lipid accumulation in 3T3-L1 adipocytes and obesity in C57BL/6J mice fed a high fat diet. J Med Food 2009; 12(4):736-45.   DOI   ScienceOn
7 Pan J, Liu G, Liu H, Qiu Z, Chen L. [Effects of artemisia capillaris on blood glucose and lipid in mice]. Zhong Yao Cai 1998;21(8):408-11.
8 Shyangdan D, Clar C, Ghouri N, Henderson R, Gurung T, Preiss D, et al. Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review. Health Technol Assess 2011;15(38):1-110.
9 Han CW, Lee JH. Effects of KHchunggan-tang on the nonalcoholic fatty liver disease in palmitate-induced cellular model. J Korean Oriental Med 2011;32(1):109-20.
10 Adams LA, Angulo P. Treatment of non-alcoholic fatty liver disease. Postgrad Med J 2006;82(967): 315-22.   DOI   ScienceOn
11 Wu JN. An illustrated Chinese materia medica. New York: Oxford University Press; 2005, p. 59, 111, 225, 235, 403, 565.
12 Hong X, Tang H, Wu L, Li L. Protective effects of the Alisma orientalis extract on the experimental nonalcoholic fatty liver disease. J Pharm Pharmacol 2006;58(10):1391-8.   DOI   ScienceOn
13 Han CW, Kang ES, Ham SA, Woo HJ, Lee JH, Seo HG. Antioxidative effects of Alisma orientale extract in palmitate-induced cellular injury. Pharm Biol 2012;50(10):1281-8.   DOI   ScienceOn
14 Lin HR. Triterpenes from Alisma orientalis act as farnesoid X receptor agonists. Bioorg Med Chem Lett 2012;22(14):4787-92.   DOI   ScienceOn
15 Li HB, Fang KY, Lu CT, Li XE. [Study on lipid-regulating function for the extracts and their prescriptions from Semen Cassiae and fructus crataegi]. Zhong yao cai 2007;30(5): 573-5.
16 Niu C, Chen C, Chen L, Cheng K, Yeh C, Cheng J. Decrease of blood lipids induced by Shan-Zha (fruit of Crataegus pinnatifida) is mainly related to an increase of PPARalpha in liver of mice fed high-fat diet. Horm Metab Res 2011;43(9):625-30.   DOI   ScienceOn
17 Wu HT, He XJ, Hong YK, Ma T, Xu YP, Li HH. Chemical characterization of Lycium barbarum polysaccharides and its inhibition against liver oxidative injury of high-fat mice. Int J Biol Macromol 2010;46(5):540-3.   DOI   ScienceOn
18 Zhao R, Li Q, Xiao B. Effect of Lycium barbarum polysaccharide on the improvement of insulin resistance in NIDDM rats. Yakugaku Zasshi 2005;125(12):981-8.   DOI   ScienceOn
19 Shin JH, Kang MJ, Yang SM, Lee SJ, sung NJ. Effects of namhae specialized crops water extract on lipid metabolism in rats fed a cholesterol diet. Korean J Food Cookery Sci 2011;27(5):599-610.   DOI
20 Luo Q, Cai Y, Yan J, Sun M, Corke H. Hypoglycemic and hypolipidemic effects and antioxidant activity of fruit extracts from Lycium barbarum. Life Sci. 2004;76(2):137-49.   DOI   ScienceOn
21 Arafa HM. Curcumin attenuates diet-induced hypercholesterolemia in rats. Med Sci Monit 2005;11(7):BR228-34.
22 Zhang ZP, You TT, Zou LY, Wu T, Wu Y, Cui L. [Effect of a compound Danshen preparation in preventing long-term gastric lipid emulsion administration-induced nonalcoholic steatohepatitis in rats]. Nan Fang Yi Ke Da Xue Xue Bao 2008;28(7):1109-13.
23 Park SH, Jeon WK, Kim SH, Kim HJ, Park DI, Cho YK, et al. Prevalence and risk factors of non-alcoholic fatty liver disease among Korean adults. J Gastroenterol Hepatol 2006;21(1Pt1): 138-43.   DOI
24 Prasad H, Ryan DA, Celzo MF, Stapleton D. Metabolic syndrome: definition and therapeutic implications. Postgrad Med 2012;124(1):21-30.   DOI   ScienceOn
25 Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999;94(9):2467-74.   DOI   ScienceOn